Key result
Whole genome sequencing diagnoses cholesteryl ester storage disease mimicking familial hypercholesterolemia.
Case Report (n=1)
This case highlights the diagnostic challenge of differentiating rare subclinical cholesteryl ester storage disease from familial hypercholesterolemia.
Background Cholesteryl ester storage disease (CESD) is a rare genetic disorder caused by homozygous or compound heterozygous pathogenic variants in the lipase A (LIPA) gene encoding lysosomal acid lipase. Lysosomal acid lipase deficiency is characterized by progressive accumulation of cholesteryl esters in hepatocytes and macrophages, ultimately leading to organ damage and potentially hepatic failure. Case summary Here we describe a girl with biochemistry similar to familial hypercholesterolemia having a total cholesterol of 9.3 mmol/L, low-density lipoprotein cholesterol of 7.1 mmol/L, triglycerides of 2.7 mmol/L and alanine transaminase of 354 U/L. Whole genome sequencing found her to be compound heterozygous for NM_000235.4:c.894G>A p.(Gln298=) and NM_000235.4:c.419G>A p.(Trp140*) in the LIPA gene, consistent with the diagnosis compound heterozygous CESD. The patient had no clinical signs of cholesterol deposits and no symptoms suggestive of organ damage. Discussion This case report highlights the difficulties in diagnosing a rare subclinical disease with similarities to familial hypercholesterolemia followed by discussion of current treatment options.
No takes yet. Share an insight, caveat, or question.
Martinsen et al. (2026) conducted a case report in Cholesteryl ester storage disease (n=1). Whole genome sequencing diagnosed cholesteryl ester storage disease in a girl with elevated total cholesterol (9.3 mmol/L) and ALT (354 U/L) mimicking familial hypercholesterolemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: